🩺 Intramuscular Injection

Intramuscular (IM) injection involves the delivery of medication into the deep muscle tissue, providing faster absorption than subcutaneous routes while avoiding the complexities of intravenous access. Common sites include the deltoid, vastus lateralis, and ventrogluteal muscles. This procedure requires strict adherence to aseptic non-touch technique (ANTT) and careful selection of the injection site and needle length based on the patient's anatomy. It is widely used for vaccinations, hormonal therapies, and emergency medications like adrenaline. Safety is paramount, focusing on correct drug administration and the prevention of needle-stick injuries.

The intramuscular route is indicated for the delivery of medications that require rapid systemic action but cannot be given orally or intravenously, such as certain antibiotics or hormonal treatments. It is used for vaccines because the high vascularity of muscle tissue facilitates an effective immune response. Patients who are non-compliant with oral therapy or are unable to swallow may require IM depot formulations of antipsychotics. It is also the emergency route of choice for adrenaline in anaphylaxis due to the rapid absorption from the vastus lateralis. Additionally, it is used for medications that are deactivated by digestive enzymes or when a sustained-release effect is desired.

Injections should be avoided in areas with active skin infection, inflammation, or scars to prevent poor absorption and further irritation. Patients with severe coagulopathy or those with a high INR on warfarin are at significant risk of haematoma formation. The technique is contraindicated if the muscle mass is insufficient for the volume of fluid to be delivered, such as in cases of extreme muscle wasting. Known hypersensitivity to the medication or its vehicle is an absolute contraindication. In patients with circulatory collapse or shock, IM absorption is unpredictable, making the intravenous route preferable.

Prescription chart and patient ID band. Clean tray, non-sterile gloves, and apron. The prescribed medication, diluent (if required), and a drawing-up needle (filter needle if using glass ampoules). An appropriate gauge needle (typically 21G green or 23G blue) of sufficient length. Syringe of appropriate volume. Alcohol swab (70% isopropyl alcohol). Gauze, adhesive plaster, and a sharps bin. Clinical waste bag.

Confirm the patient’s identity, explain the procedure, and obtain verbal consent. Review the prescription chart and check for allergies. Screen the patient for privacy and select an appropriate site (usually the deltoid or vastus lateralis). Perform hand hygiene and don gloves. Clean the site with an alcohol swab for 30 seconds and allow it to air dry. Prepare the medication using an aseptic non-touch technique (ANTT). Stretch the skin or use the Z-track method. Insert the needle at a 90-degree angle with a swift motion. Inject the medication slowly and steadily. Withdraw the needle quickly, apply gentle pressure with gauze (do not massage), and safely dispose of the sharps. Document the procedure clearly in the patient's notes.

Post-procedure monitoring is essential to interpret the patient's response to the medication and to detect immediate adverse effects. The clinician should observe for signs of anaphylaxis or local allergic reactions for at least 15–30 minutes, especially with vaccines. The injection site should be inspected for signs of haematoma or persistent bleeding. Documentation must include the drug name, dose, site of administration (e.g., Left Deltoid), batch number (for vaccines), and the patient’s tolerance of the procedure. A successful injection is marked by the absence of immediate complications and the subsequent clinical improvement related to the drug's action.

Choosing an inappropriate needle size for the patient's muscle mass is a frequent mistake; a green needle is often necessary for the ventrogluteal site in adults to ensure deposition into the muscle rather than subcutaneous fat. Failure to aspirate (though no longer strictly required for all sites by some guidelines, it remains common practice for the dorsogluteal site) or injecting too quickly can cause unnecessary pain. Forgetting to rotate injection sites in patients receiving regular medication can lead to sterile abscesses or muscle fibrosis. Misidentifying landmarks, particularly for the ventrogluteal site, can lead to accidental nerve injury or intravascular injection.

Always confirm the patient's identity using three identifiers and check for allergies before preparing the medication. Clearly state the anatomical landmarks you are using to the examiner (e.g., 'three finger widths below the acromion process' for the deltoid). Use the Z-track technique by pulling the skin 2-3cm to one side before inserting the needle at 90 degrees; this seals the medication in the muscle. Do not recap the needle; dispose of it immediately into the sharps bin at the bedside. Always offer a plaster but check for adhesive allergies first.

This skill aligns with the MLA 'Clinical Skills' syllabus under 'Practical Procedures'. Students must demonstrate safe sharps handling and the 'Six Rights' of medication administration. Understanding the anatomical landmarks for the deltoid, vastus lateralis, and ventrogluteal muscles is a frequent assessment area. Knowledge of the Z-track technique to prevent medication leakage is highly valued. The MLA also expects students to be able to communicate effectively with the patient regarding potential side effects and the rationale for the choice of route.